All Updates

All Updates

icon
Filter
Partnerships
Massive Bio expands partnership with Un Ensayo Para Mi to improve clinical trial access in Latin America
Clinical Trial Technology
Jun 3, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Jun 3, 2024

Massive Bio expands partnership with Un Ensayo Para Mi to improve clinical trial access in Latin America

Partnerships

  • Massive Bio, a provider of AI-driven oncology solutions, has partnered with Un Ensayo Para Mi (UEPM), a prominent Latin American clinical trial search platform.

  • The partnership aims to expand access to crucial clinical trials to nine countries in the Latin America region, including Mexico, Colombia, Brazil, and Argentina.

  • The alliance between Massive Bio and UEPM will utilize the network of UEPM and Massive Bio's AI technology to create a more accessible and efficient clinical trial enrollment process for cancer patients in Latin America. The partnership is expected to align innovative treatments with the patients most in need. Integrating Massive Bio's AI solutions into UEPM's platform also promises to speed up and improve the accuracy of matching patients with suitable clinical trials, which could increase participation rates and advance cancer research in the region.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.